We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.18B
AUM Growth
-$215M
Cap. Flow
+$233M
Cap. Flow %
10.67%
Top 10 Hldgs %
53.45%
Holding
100
New
9
Increased
46
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.3M
2
BIIB icon
Biogen
BIIB
+$45.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.2M
4
MRK icon
Merck
MRK
+$26.9M
5
STJ
St Jude Medical
STJ
+$25.3M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$26.6M
2
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$25.4M
3
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$25.3M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$21.7M
5
HALO icon
Halozyme
HALO
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTLT
76
DELISTED
CATALENT, INC.
CTLT
$473K 0.02%
19,449
+1,527
+9% +$46.4K
CHRS icon
77
Coherus Oncology
CHRS
$219M
$331K 0.02%
16,498
+524
+3% +$15.9K
ABT icon
78
Abbott
ABT
$190B
– –
-541,734
Closed -$26.6M
ARAY icon
79
Accuray
ARAY
$28M
– –
-2,395
Closed -$16K
BAX icon
80
Baxter International
BAX
$12.8B
– –
-580
Closed -$22K
BDX icon
81
Becton Dickinson
BDX
$46.1B
– –
-215
Closed -$30K
BSX icon
82
Boston Scientific
BSX
$67.3B
– –
-1,870
Closed -$33K
HCA icon
83
HCA Healthcare
HCA
$90.9B
– –
-175,945
Closed -$16M
HOLX
84
DELISTED
Hologic
HOLX
– –
-225
Closed -$9K
IART icon
85
Integra LifeSciences
IART
$1.36B
– –
-232
Closed -$6K
SYK icon
86
Stryker
SYK
$134B
– –
-420
Closed -$40K
TNDM icon
87
Tandem Diabetes Care
TNDM
$1.22B
– –
-65
Closed -$7K
UHS icon
88
Universal Health Services
UHS
$10.1B
– –
-67,146
Closed -$9.54M
ZBH icon
89
Zimmer Biomet
ZBH
$18.7B
– –
-252
Closed -$27K
NVTA
90
DELISTED
Invitae Corporation
NVTA
– –
-929,765
Closed -$13.8M
CYTO
91
DELISTED
Altamira Therapeutics Ltd
CYTO
– –
-3
Closed -$1.11M
CSII
92
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-285
Closed -$8K
CLVS
93
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-246,952
Closed -$21.7M
XENT
94
DELISTED
Intersect ENT, Inc
XENT
– –
-320
Closed -$9K
VAR
95
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-131
Closed -$10K
ACHN
96
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-98,400
Closed -$872K
ENTL
97
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-505
Closed -$13K
SPNC
98
DELISTED
Spectranetics Corp
SPNC
– –
-230
Closed -$5K
THOR
99
DELISTED
THORATEC CORPORATION
THOR
– –
-250
Closed -$11K
TRNX
100
DELISTED
TORNIER N V SHARES (NLD)
TRNX
– –
-395
Closed -$10K
1 2 3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Sectoral Asset Management held 100 positions worth $2.18B, down 9% from $2.4B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sectoral Asset Management deployed $233M of net new capital in Q3 2015, opening 9 new positions and adding to 46 existing holdings. Its largest new stake was Sierra Oncology, Inc. Common Stock: 21,569 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 91% a quarter earlier.

On the sell side, the largest reduction was ZS PHARMA INC COMS TK (DE), an estimated $25.4M trimmed.

  • Sectoral Asset Management's largest Q3 2015 buy was Sierra Oncology, Inc. Common Stock: 21,569 shares worth $17.3M.
  • Sectoral Asset Management added most to Gilead Sciences in Q3 2015, an estimated $61.3M increase.
  • Sectoral Asset Management's biggest Q3 2015 reduction was ZS PHARMA INC COMS TK (DE), cutting an estimated $25.4M.
  • Sectoral Asset Management fully exited Abbott in Q3 2015, selling an estimated $26.6M.
  • Sectoral Asset Management's ten largest holdings make up 53% of its $2.18B portfolio in Q3 2015.
  • Sectoral Asset Management opened 9 new positions and closed 23 in Q3 2015.
  • Sectoral Asset Management's portfolio value fell 9% quarter-over-quarter to $2.18B.

Based on Sectoral Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.